Drug Profile
Research programme: dual angiotensin receptor antagonists/PPAR gamma agonists - Kowa
Alternative Names: K-21299Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Kowa
- Class
- Mechanism of Action Angiotensin receptor antagonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic nephropathies
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetic-nephropathies in Japan (PO)
- 14 Sep 2011 Preclinical trials in Diabetic nephropathies in Japan (PO)
- 14 Sep 2011 Pharmacodynamics data from preclinical studies in Diabetic nephropathy presented at the 47th Annual meeting of the European Association for the Study of Diabetes (EASD-2011)